Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-892-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-11-23 to 2009-12-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Deviations:
- The humidity of the animal room was lower than the SOP stated minimum value of 30% on 7, 8, and 10-13 December 2009 (19%-25%). The temperature of the animal room exceeded the SOP stated range of 18°C – 26°C on 8 December 2009 (range = 17.4°C – 29.0°C). The magnitude and duration of these changes did not have an effect on the study outcome.
- As per protocol, the mice were supposed to be 8-12 weeks of age at start of dosing. The mice were approximately 7 weeks of age on the first day of dosing. This deviation did not have an impact on the study evaluation. - Deviations:
- yes
- Remarks:
- For the deviations explanation, please check the textbox above "Version/remarks"
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction mass of butyl palmitate and butyl oleate and butyl (9Z,12Z)-octadeca-9,12-dienoate and 482-680-2
- EC Number:
- 944-892-8
- Molecular formula:
- not applicable
- IUPAC Name:
- Reaction mass of butyl palmitate and butyl oleate and butyl (9Z,12Z)-octadeca-9,12-dienoate and 482-680-2
- Test material form:
- liquid: viscous
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- Weight Range: 16.6 to 21.9 grams on 09 Dec 2009, the day before dosing.
Age: Approximately 7-8 weeks at start of dosing.
Indeitification: Animal numbers marked on tails in permanent ink.
Animal housing: Group housed with up to 5 mice per cage during acclimation and then housed individually for remainder of study.
Cage identification: Labeled with study number, animal number, treatment, and dose.
Room temperature: 17.4°C - 29.0°C.
Cage Bedding: Bed-o' cobs.
Relative Humidity: 19% - 48%.
Lighting: 12-hour light/12-hour dark cylce.
Acclimation: 7 days.
Food: PMI(R) LabDiet(R) (5002 Certified Rodent Diet)
Water: Town of Cary tap water ad libitum.
Clinical Observations: Mice were monitored daily.
The were no contaminants in the food or water that were known to influence the outcome of the study. The animal supplier's Animal Health Report (performed quarterly) does not indicate levels of bacteria or other pethogens that would have changed the outcome of the study.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 10%, 25%, and 50% v/v in AOO and 100% (undiluted)
- No. of animals per dose:
- 8 animals/vehicle control group (AOO).
5 animals/test-article treatment group.
5 animals/positive control group (isoeugenol) - Details on study design:
- The mice were restrained by hand, and 25 µL of test or control article was supplied daily for 3 consecutive days to the dorsum of each ear using a calibrated Finnpipette(R). The animals were allowed to rest without dosing on Days 4 and 5. The mice were observed daily for signs of toxicity or irritation.
Ear measurements were taken prior to dosing on Days 1 and 3 using an Oditest micrometer (Kroeplin; The dyer Company, Lancaster, PA). Percentage increase in ear thickness from Day 1 to Day 3 was calculated.
Assay procedures were performed as per SOP BRT 601-04. In brief, on Day 6, individually nulbered mice wre injected in the lateral tail vein with 0.25 mL containing 2 µCi of 125I-labelled and 10-5 M FuDR in phosphate-buffered saline (PBS). Approximately 5 hours later, the mice were euthanized by CO2 asphyxiation, and the auricular lymph nodes were excised. The nodes were dissociated using the frosted ends of glass slides. The cell suspension was washed with Hanks' balanced salt solution and then with PBS prior to being resuspended in 5% trichloroacetic acid (TCA) and refrigerated at approximately 4°C. The following day, the cells were centrifuged and resuspended in fresh 5% TCA. The radioactivity was measured using a gamma counter (Packard Instrument). - Positive control substance(s):
- other: Isoeugenol
- Statistics:
- The natural log-transformed DPM values for the test article and positive control were compared against vehicle for variance homogeneity using Bartlett’s chi-square test. Compounds with nonsignificant Bartlett’s chi-square values were evaluated with one-way analysis of variance (ANOVA) using dose (concentration). If the ANOVA values fit (p < 0.05), Dunnett’s t test was applied to determine which concentrations were different from vehicle by statistically significant margins. For compounds with significant Bartlett’s chi-square terms, the nonparametric Kruskal-Wallis (KW) test was applied. Significant (p < 0.05) KW test results were further analyzed with the Jonckheere–Terpstra test for dose-dependent trends.
The concentration of chemical required to elicit an SI of 3 (EC-3) was determined from the appropriate regression equation. Stimulation index values from the test article concentrations were fit using a quadratic equation. If the quadratic term did not fit, linear regression was used. Because the positive control had only two data points, a linear equation was used to fit the positive control SI data.
To determine EC-3 potency, the derived EC-3 value is expressed in terms of dose per unit area of skin, assuming a conversion of 1 milliliter to 1 gram. With 25 L of test article applied to an exposure area of 1 cm2 per mouse ear, potency values were calculated by multiplying the EC-3 by 250.
Ear thickness measurements were checked for 10%-or-greater increases between Day 1 and Day 3. When applicable, the lowest concentration to elicit such an increase (minimal irritating concentration or MIC10) was determined. The MIC10 was then compared to the calculated EC-3. If the MIC10 was greater than the EC-3 (MIC10 > EC-3), confounding irritation is unlikely to have affected the LLNA.
All calculations were performed using Microsoft® Excel and SAS®, version 9.1. The following SAS statistical procedures were utilized: GLM, FREQ, NPAR1WAY, and MEANS.
Results and discussion
- Positive control results:
- The positive control, isoeugenol at 5%, has a statistically significant SI value of 7.9. Isoeugenol has an EC-3 of 1.5 % and an EC-3 potency value of 375 g/cm2, making it a moderate sensitizer (potency value between 100 and 1,000 g/cm2) (Gerberick et al., 2001).
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1
- Variability:
- SE (standard error of the mean) : 0.2
- Test group / Remarks:
- 5 alpha Avocuta in AOO - 10%
- Remarks on result:
- other: no indication of skin sensitisation
- Key result
- Parameter:
- SI
- Value:
- 1.1
- Variability:
- SE (standard error of the mean): 0.2
- Test group / Remarks:
- 5 alpha Avocuta in AOO - 25%
- Remarks on result:
- other: no indication of skin sensitisation
- Key result
- Parameter:
- SI
- Value:
- 1.3
- Variability:
- SE (standard error of the mean): 0.3
- Test group / Remarks:
- 5 alpha Avocuta in AOO - 50%
- Remarks on result:
- other: no indication of skin sensitisation
- Key result
- Parameter:
- SI
- Value:
- 2.7
- Variability:
- SE (standard error of the mean): 0.5
- Test group / Remarks:
- 5 alpha Avocuta in AOO - 100%
- Remarks on result:
- other: no indication of skin sensitisation
- Key result
- Parameter:
- SI
- Value:
- 7.9
- Variability:
- SE (standard error of the mean): 0.8
- Test group / Remarks:
- Isoeugenol in AOO - 5%
- Remarks on result:
- other: validation of positive control
- Key result
- Parameter:
- EC3
- Remarks:
- %
- Value:
- > 100
- Test group / Remarks:
- 5 alpha Avocuta
- Key result
- Parameter:
- EC3
- Remarks:
- %
- Value:
- 1.5
- Test group / Remarks:
- Isoeugenol
- Cellular proliferation data / Observations:
- The natural log DPM values are not increased in a dose-related manner.
Any other information on results incl. tables
Ear measurement Summary Table
Treatment | Mean % increase | SE (Standard error of the mean) |
AOO Vehicle Control | 0.2 | 0.22 |
5 alpha Avocuta in AOO - 10% | 0.6 | 0.50 |
5 alpha Avocuta in AOO - 25% | 0.8 | 0.51 |
5 alpha Avocuta in AOO - 50% | 2.2 | 0.50 |
5 alpha Avocuta - 100% | 2.5 | 0.56 |
Isoeugenol in AOO - 5% | 1.6 | 0.63 |
Applicant's summary and conclusion
- Interpretation of results:
- other: not considered a sensitizer
- Conclusions:
- A substance is considered a sensitizer if at least one concentration of the test material results in an SI of 3 or more. None of the SI values for 5 alpha Avocuta(R) are greater than 3 (SI value are 1.0, 1.1, 1.3, and 2.7 for the 10%, 25%, 50%, and 100% concentrations, respectively). The natural log DPM values are not increased in a dose-related manner and the calculated EC-3 is greater than 100%. Therefore, 5 alpha Avocuta(R) is not considered a sensitizer under the conditions of this study.
- Executive summary:
This study evaluated the test article 5 α Avocuta® in one local lymph node assay in mice (one study number/protocol for the study). The report contained herein is for test article 5 α Avocuta®.
Mice were treated daily for 3 consecutive days by direct epicutaneous application of 25 µL of test or control article to the dorsum of each ear. Test article 5 α Avocuta® was tested at 10%, 25%, and 50% final concentrations in acetone/olive oil 4:1 (AOO) and at 100% (undiluted). The control articles included the vehicle control (AOO) and a known sensitizer, isoeugenol, which was tested at 5% in acetone/olive oil 4:1 (AOO). The mice were observed daily. Three days after the final auricular application, the animals were injected intravenously with 125I- labeled Iododeoxyuridine to label proliferating cells. 125I-incorporation was quantified using a gamma counter.
There were no compound-related changes in body weights. All animals in the 100% 5 α Avocuta® group had clinical observations of slight ear swelling. But the measured increase in mean ear thickness was less than 10% for this treatment group and all other 5 α Avocuta®, AOO control, and isoeugenol groups. Thus primary irritation is unlikely to have affected the LLNA stimulation indices for this study. There were no other compound-related clinical observations.
A substance is considered a sensitizer if at least one concentration of the test material results in an SI of 3 or more. None of the SI values for 5 α Avocuta® are greater than 3 (SI values were 1.0, 1.1, 1.3, and 2.7 for the 10%, 25%, 50%, and 100% concentrations, respectively). The natural log DPM values are not increased in a dose-related manner and the calculated EC-3 is greater than 100%. Therefore, 5 α Avocuta® is not considered a sensitizer under the conditions of this study.
The positive control, isoeugenol at 5%, has a statistically significant SI value of 7.9. Isoeugenol has an EC-3 of 1.5 % and an EC-3 potency value of 375 µg/cm2, making it a moderate sensitizer (potency value between 100 and 1,000 µg/cm2) (Gerberick et al., 2001). This is consistent with previously reported results.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.